Trials Starting With "A"

A-4: Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation

      -Trial Overview by Dr. Pierre Jais (Heart Rhythm Society Meeting 2006)

A-F: Angioplasty Balloon-Associated Coronary Debris and the EZ FilterWire Trial

      -Vascular Protection in High-Risk Non-ST Elevation Acute Coronary Syndromes: Angioplasty Balloon-associated Coronary Debris and the EZ FilterWire by Dr. M. Webster

A-Heft: African-American Heart Failure

      -Trial Overview by Dr. A.L. Taylor (AHA 2004)

ABOARD: Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndromes Randomized for an Immediate or Delayed Intervention

      -A Multicenter Randomized Trial of Immediate Versus Delayed Invasive Strategy in Patients with Non-ST Elevation ACS by Dr. G. Montalescot

ABSORB: Immediate Versus Next Day Catheterization In Non-St Elevation Acute Coronary Syndrome

      -Trial Overview by Dr. Patrick W. Serruys (ACC 2007)

      -Trial Overview by Dr. Patrick W. Serruys (ACC 2007) Spanish

ABSOLUTE: Randomized Comparison Between Sirolimus (Cypher)/Sirolimus - analogous (Xience; Promus) vs. Paclitaxel (Taxus vs. Costar) Eluting Stents in Coronary Lesions

      -A Single Center Experience by Dr. Alaide Chieffo

 

ACCESS Registry: Management of Acute Coronary Syndromes in Developing Countries

      -Overview by Dr. Mohamed Sobhy (C3 Complex Intervention Meeting 2011)

ACCESS-EUROPE: An Observational Study of the MitraClip System in Europe

      -1-Year Outcomes by Dr. Wolfgang Shillinger (ESC 2012)

ACCF-STS: Survival after PCI or CABG in Older Patients with Stable Multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies

      -Trial Results by Dr. William S. Weintraub (ACC 2012)

 

ACCORD: The Action to Control Cardiovascular Risk in Diabetes Lipid Trial

      -Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus by Dr. Henry N. Ginsberg (ACC 2010)

ACRIN PA 4005: A Multicenter Randomized Controlled Study of a Rapid 'Rule-out' Strategy Using CT Coronary Angiogram Versus Traditional Care for Low-Risk ED Patients with Potential ACS

      -Trial Overview by Dr. Harold Litt (ACC 2012)

 

ACT: Acetylcysteine For the Prevention of Contrast-Induced Nephropathy

      -Trial Overview by Dr. Otavio Berwanger (AHA 2010)

ACORN: Assessment Of A Cardiac Support Device (Csd) In Patients With Heart Failure

      -Trial Overview by Dr. D.L. Mann (AHA 2004)

ACT34-CMI: Adult Autologous CD34+ Stem Cells

      -Study Overview by Dr. Douglas W. Losordo

ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS (gastrointestinal therapeutic system)

      -Trial Overview by Dr. Philip A Poole-Wilson

ACTION Registry: Acute Coronary Treatment and Intervention Outcomes Network

      -An ACC and AHA? Effort to Improve MI Care by Dr. Eric Peterson (AHA 2007)

ACTIVATE: Acyl-coenzyme A:cholesterol acyltransferase (ACAT) Inhibition on the Progression of Coronary Atherosclerosis

      -Trial Overview by Dr. Steven E. Nissen (AHA 2005)

ACTIVE A: Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention of Vascular Events - A

      -Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists

ACTIVE W: Atrial Fibrillation Clopidogrel Trial with Irbesartan For Prevention of Vascular Events - W

      -Trial Overview by Dr. Stuart J. Connolly (AHA 2005)

ACUITY: Acute Catheterization and Urgent Intervention Triage Strategy Trial

      -ACUITY: Long Term Results & SPIRIT III: Trial designed to compare Abbott's XIENCE V Everolimus Eluting Coronary Stent System with Boston Scientific's TAXUS Paclitaxel-Eluting Coronary Stent System by Dr. Gregg W. Stone

      -Major Bleeding is Associated with Increased One-Year Mortality and Ischemic Events in Patients with Acute Coronary Syndromes Undergoing PCI by Dr. Steven V. Manoukian et al. (TCT 2007)

      -Impact of Transfusion on One-Year Ischemic Events and Mortality Among Patients with Acute Coronary Syndromes Undergoing PCI by Dr. Steven V. Manoukian (TCT 2007)

      -Impact of Anemia on One-Year Ischemic Events and Mortality Among Patients with Acute Coronary Syndromes Undergoing PCI by Dr. Steven V. Manoukian (TCT 2007)

      -Predictors of Major Vascular Access Site Complications in Patients with Acute Coronary Syndromes Undergoing PCI: Insights from the ACUITY Trial by Dr. Steven V. Manoukian (TCT 2007)

      -Resultados Finales del Ensayo Clínico ACUITY (1 año) by Dr. Gregg Stone (ACC 2007) Spanish

      -Major Bleeding is Associated with Increased Short-Term Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes by Dr. Steven V. Manoukian (AHA 2006)

      -Transfusion is Associated with Increased 30-Day Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes by Dr. Steven V. Manoukian et al. (TCT 2006)

      -Major Bleeding is Associated with Increased 30-Day Mortality and Ischemic Complications in Patients with Non-ST Elevation Acute Coronary Syndromes Undergoing PCI by Dr. Steven V. Manoukian (TCT 2006)

      -Implications of Preoperative Thienopyridine Use Prior to CABG: A Report from the ACUITY Trial by Dr. Ramin Ebrahimi (TCT 2006)

      -Implications of Preoperative Thienopyridine Use Prior to CABG by Dr. Ramin Ebrahimi (TCT 2006)

      -Bivalirudin Monotherapy Improves 30-day Clinical Outcomes in Diabetics with ACS by Dr. Frederick Feit (AHA 2006)

      -Is Bivalirudin Monotherapy Sufficient for Diabetic Patients with Acute Coronary Syndrome Undergoing PCI? by Dr. Frederick Feit (TCT 2006)

      -Safety and Effectiveness of Bivalirudin in NSTE ACS by duration of the upstream infusion in the ACUITY trial: Implications for ED and upstream management by Dr. Charles Pollack (AHA 2006)

      -Safety and Effectiveness of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial by Dr. David Cox (TCT 2006)

      -Cost-Effectiveness in ACS: The ACUITY Economic Study by Dr. David J. Cohen (TCT 2006)

      -Gender Differences in Outcomes Following PCI of Patients with Non-ST Elevation Acute Coronary Syndrome by Dr. Ken Mori (TCT 2006)

      -Safety and Efficacy of Crossover (Switch) from UFH/Enox to Bivalirudin: Results from ACUITY by Dr. Harvey White (AHA 2006)

      -Optimal Upstream Antithrombin Therapy in NSTE ACS PAtients Managed in the Cardiac Cath Lab: Does it Matter Which Agent is Started in the ED? by Dr. Charles V. Pollack (2006)

      -Outcomes in Elderly Patients Undergoing PCI Treated with Bivalirudin Monotherapy vs. Glycoprotein IIb/IIIa Inhibitors with Heparin or LMWH by Dr. Karen P. Alexander (TCT 2006)

      -Prospective, Randomized Comparison of Heparin Plus IIb/IIIa Inhibition and Bivalirudin with or without IIb/IIIa Inhibition in Patients with ACS by Dr. Gregg W. Stone

      -The Time Dependence of Anti-thrombin Initation in Patients with Non-ST-segment-elevation ACS: Subgroup Analysis from the Acuity Trial by Dr. Deborah B. Diercks

      -Subacute Stent Thrombosis in Patients with ACS Treated with Bare Metal and Drug-Eluting Stents by Dr. Jiro Aoki

      -ACUITY Results

      -Prospective, Randomized Comparison of Heparin Plus IIb/IIIa Inhibition and Bivalirudin With or Without IIb/IIIa Inhibition in Patients with ACS by Dr. Gregg W. Stone

      -Final One-Year Results by Dr. Gregg W. Stone

      -Angiographic Findings in the ACUITY Trial by Dr. Alexandra J. Lansky

      -Anemia is Associated with Increased One-Year Mortality and Ischemic Events in Patients with ACS: Results from the ACUITY Trial by Dr. Steven V. Manoukian

      -Major Bleeding is Associated with Increased One-Year Mortality and Ischemic Events in Patients with ACS: Results from the ACUITY Trial by Dr. Steven V. Manoukian

      -Transfusion is Associated with Increased 30-Day Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes: The ACUITY Trial by Dr. Steven V. Manoukian

ACUITY PCI: Acute Catheterization and Urgent Intervention Triage Strategy Timing Trial - PCI Subgroup

      -A Prospective Trial of Patients with ACS Undergoing PCI after Randomization to Heparin plus GP IIb/IIIa Inhibitors vs. Bivalirudin With or Without GP IIb/IIIa Inhibitors by Dr. Gregg W. Stone

ACUITY Timing: Acute Catheterization and Urgent Intervention Triage Strategy Timing Trial

      -Prospective, Randomized Comparison of Routine Upfront Initiation Versus Selective Use of Glycoprotein IIb/IIIa Inhibitors in Patients with ACS: The ACUITY Timing Trial by Dr. Gregg W. Stone

 

Acute Coronary Syndromes: What's Current? What's New? What's Next?

      -Overview by Dr. Robert Harrington

 

Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy): Clinical Correlates and Mayo Clinic Risk Score

      -Overview by Dr. Abhiram Prasad

ADAPT-DES: A Large-Scale, Multicenter, Prospective, Observational Study of the Impact of Clopidogrel Hyporesponsiveness on Patient Outcomes

      -Trial Overview by Dr. Gregg W. Stone (TCT 2011)

      -Trial Overview by Dr. Gregg W. Stone (AHA 2011)

      -One-Year Results by Dr. Gregg W. Stone (TCT 2012)

ADHERE: Acute Decompensated Heart Failure National Registry

      -Admission B-Type Natriretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure by Dr. Gregg C. Fonarow (2007)

ADMIRAL: Abciximab before Direct angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up

      -30-Day Results (ESC 1999)

      -6-month Results

      -ADMIRAL vs. CADILLAC

ADVANCE: Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Released Control Evaluation

      -Trial Overview

 

ADVANCE: Evaluation of the HeartWare HVAD Left Ventricular Assist System for the Treatment of Advanced Heart Failure

      -Trial Results of the ADVANCE Bridge to Transplant Trial by Dr. Keith Aaronson (AHA 2010)

 

The ADVANCE Trial: The Additive Value of Tirofiban Administered With the High-Dose Bolus in the Prevention of Ischemic Complications During High-Risk Coronary Angioplasty

      -Trial Overview by Dr. M. Valgimigli (Oct 2004)

 

ADVISE: Validation of a Vasodilator Independent Measure of Coronary Fractional Flow Reserve

      -Trial Overview by Dr. Justin Davies (TCT 2011)

AFCAPS/TexCAPS: Air Force Texas Coronary Atherosclerosis Prevention Study

      -Primary Prevention of Acute Coronary Events with Lovastatin in Men and Women with Average Cholesterol Levels: Results of AFCAPS/TexCAPS by Dr. John R. Downs

AFIST-III: Atrial Fibrillation Suppressions Trial III

      -Impact of Epicardial Anterior Fat Pad Retention on Postcardiothoracic Surgery Atrial Fibrillation Incidence: The AFIST-III Study by C. Michael White, PharmD

AGENT III: Angiogenic Gene Therapy - 3

      -12-Week Results (TCT 2004)

      -A Multicenter, Prospective, Randomized Trial of Intracoronary Administration of Ad5FGF-4 in Patients With No Revascularization Options (AGENT-3) Trial by Dr. Timonthy Henry (ACC 2005)

AGIR-2

      -Comparison of Pre-hospital or Cath lab Administration of High Dose Tirofiban in Patients Undergoing Primary Angioplasty by Dr. Eric Bonnefoy (ACC 2009)

A to Z: Aggrastat to Zocor Trial

      -Aggrastat-Phase of the A to Z Trial (ACC 2003)

AIDA STEMI MRI: Cardiac MRI Substudy from a Prospective, Randomized Trial of Intracoronary Abciximab in Patients with ST-Segment Elevation Myocardial Infarction

      -Study Overview by Dr. Holger Thiele (TCT 2012) 

AiMI: Angiojet in Acute Myocardial Infarction Trial

      -Trial Overview (ACC 2006)

      -AiMI: AngioJet Rheolytic Thrombectomy in Patients Undergoing Primary Angioplasty for Acute MI (TCT 2004)

Aliskiren and Valsartan for Antihypertensive Therapy Trial

      -Trial Overview (ACC 2007)

ALKK: Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte

      -PTCA in stable survivors of acute MI vs medical therapy (2003)

ALLHAT: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

      -Trial Overview (2002)

ALLHAT-LLT: Lipid Lowering Substudy Trial of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

      -Trial Overview (2002)

 

ALPHA OMEGA: Effect of Low Doses of N-3 Fatty Acids on Cardiovascular Diseases in Post-MI Patients

      -Trial Overview by Dr. Daan Kromhout (ESC 2010)

 

 

ALPHEE: Double Blind Placebo Controlled Dose Ranging Study Of the Efficacy and Safety Of Celivarone 50, 100, 300 Mg OD with Amiodarone as Calibrator for the Prevention Of ICD Interventions or Death

      -Trial Overview by Dr. Peter Kowey (AHA 2011)

AMEthyst: Assessment of the Medtronic Ave Interceptor Saphenous Vein Graft Filter System

      -A Prospective Randomized Controlled Study of the Medtronic Interceptor® PLUS Coronary Filter System for PCI of Degenerative SVG by Dr. Dean Kereiakes (TCT 2007)

AMIHOT: Acute Myocardial Infarction with Hyperoxemic Therapy

      -Aqueous Oxygen Therapy Improves ST-Segment Resolution in Anterior Myocardial Infarction (TCT 2004)

AMISTAD II: Acute Myocardial Infarction Study of Adenosine II

      -Trial Overview

ANTHEM-TIMI 32 Trial: Anticoagulation With Rnapc2 to Eliminate Mace/TIMI 32

      -Potential Utility of rNAPC2 in ACS: Phase 2 Heparin Replacement Trial Evaluating RNAPc2 in Acute Coronary Syndromes by Dr. Robert P. Giugliano

      -Trial results

APAF: Ablation for Paroxysmal Atrial Fibrillation Trial

      -Trial Overview by Dr. Carlo Pappone (ACC 2006)

APEX AMI: Assessment of Pexelizumab in Acute Myocardial Infarction

      -Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary PCI (2007)

 

APPOSITION II: A Prospective Randomized Trial of Self-Expanding vs. Balloon Expandable Stents in Patients with Acute Myocardial Infarction.

      -Trial Overview by Dr. Robert-Jan van Geuns (TCT 2010)

 

 

APPRAISE-1: Safety of the Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial

      -Trial Overview by Dr. John H. Alexander (ESC 2008)

 

APPRAISE-2: Apixaban with Antiplatelet Therapy After Acute Coronary Syndrome

      -Trial Results by Dr. John H. Alexander

 

APPROVE: Angiomax Peripheral Procedure Registry of Vascular Events Trial

      -Trial Overview

ARBITER-2: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 Trial

      -Trial Overview by Dr. A. Taylor (AHA 2004)

ARCHER: ACCULINK for Revascularization of Carotids in High-Risk patients Trial

      -Stenting with or without Protection in High-Risk Patients with Moderate to High-Grade Carotid Stenosis (ACC 2003)

 

ARCTIC: Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation

    -A Double Randomization of a Monitoring Adjusted Antiplatelet Treatment Versus a Common Antiplatelet Treatment for DES Implantation, and Interruption Versus Continuation of Double Antiplatelet Therapy by Dr. Jean-Philippe Collet (TCT 2010)

     -Trial Overview by Dr. Gilles Montalescot (AHA 2012)

 

ARISE: Aggressive Reduction of Inflammation Stops Events

      -Trial Overview by Dr. Jean-Claude Tardif (ACC 2007)

 

ARISTOTLE: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Trial Results by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

      -Efficacy and Safety by Dr. Christopher Granger and Dr. Lars Wallentin (ESC 2011)

 

ARISTOTLE Sub-analysis in Japanese patients: Apixaban versus Warfarin in Patients with Atrial Fibrillation

      -Study Overview by Dr. Shinya Goto (ACC 2012)

 

ARISTOTLE CHADS Subgroup Study: Efficacy and Safety of Apixaban Compared with Warfarin According to Patient Risk of Stroke and Bleeding in Atrial Fibrillation

      -Study Overview by Dr. Renato Lopes (ACC 2012)

ARMYDA: Atorvastatin for Reduction of Myocardial Damage During Angioplasty Trial

      -Trial Overview by Pasceri V, et al (2004)

 

ARMYDA-150: High Vs. Standard Clopidogrel Maintenance Dose After Percutaneous Coronary Intervention: Effects on Platelet Inhibition, Endothelial Function, and Inflammation

      -Trial Overview by Giuseppe Patti (CRT 2011)

ARMYDA-2: Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty 2 Trial

      -Trial Overview by Dr. Germano Di Sciascio (ACC 2005)

ARMYDA-3: Atorvastatin for Reduction of Myocardial Dysrhythmias After Cardiac Surgery Trial

      -Trial Overview by Dr. Giusepee Patti (ACC 2006)

ARMYDA-4: Antiplatelet Therapy for Reduction of Myocardial Damage during Angioplasty 4 Trial

      -Prospective, multicenter, randomized, double blind trial investigating influence on PCI outcome of additional 600 mg clopidogrel load in patients on chronic therapy - "ARMYDA-Reload" by Dr. Germano Di Sciascio

ARMYDA-5: Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty Trial

      -Prospective, multicenter, randomized trial investigating influence on outcome of in-lab 600 mg clopidogrel loading vs 6-hour pre-PCI treatment - "ARMYDA-Preload" by Dr. Germano Di Sciascio (TCT 2007)

      -Trial Overview by Dr. Germano Di Sciascio and  Dr. Giuseppe Patti (ESC 2010)

 

ARMYDA-ACS: Atorvastatin for Reduction of Myocardial Damage During Angioplasty - Acute Coronary Syndromes Trial

      -Multicenter, Randomized, Double Blind, Prospective Study Evaluating Effects on Outcome of Atorvastatin Pre-Treatment in Patients with Acute Coronary Syndromes Undergoing Early PCI by Dr. Germano Di Sciascio

ARMYDA Recapture: Atorvastatin for Reduction of Myocardial Damage during Angioplasty - Recapture Trial

      -Prospective, multicenter, randomized, double blind trial investigating efficacy of atorvastatin reload in patients on chronic statin therapy undergoing PCI by Dr. Germano Di Sciascio

ARMYDA-Reload: Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty - Reload Trial

      -Prospective, Multicenter, Randomized Double Blind Trial Investigating Influence on PCI Outcomes of Additional 600 mg Clopidogrel Load in Patients on Chronic Therapy - "ARMYDA-Reload" by Dr. Germano Di Sciascio (ACC 2008)

ARNO: Antithrombotic Regimens and Outcome Trial

      -A Randomized Trial Comparing Bivalirudin with Unfractionated Heparin in Patients Undergoing Elective PCI by Dr. David Antoniucci (TCT 2007)

 

ART: Randomized Trial to Compare Bilateral Versus Single Internal Mammary Coronary Artery Bypass Grafting (CABG)

      -One-Year Results of the Arterial Revascularization Trial by Dr. David P. Taggart (ESC 2010)

ARTS-II: Arterial Revascularization Therapies Study Part II

      -A Non-randomized Comparison of Contemporary PCI and CABG in Patients with Multi-Vessel Coronary Artery Lesions (ACC 2005)

 

ASCEND-HF: Acute Study of Clinical Effectivenes of Nesiritide in Decompensated Heart Failure

      -Historical Perspective, Implications for Patients Failure Trial by Dr. Adrian Hernandez (AHA 2010)

 

 ASPIRE: Aspirin for the Prevention of Recurrent Venous Thromboembolism After a First Unprovoked Event

      -Trial Results (AHA 2012)

 

ASSENT-2: Assessment of the Safety and Efficacy of a New Thrombolytic: Tnk-Tpa-2

      -Trial Overview

ASSENT-3: Assessment of the Safety and Efficacy of a New Thrombolytic Regimen - 3 Trial

      -Trial Overview

ASSENT-3 Plus: Assessment of the Safety and Efficacy of a New Thrombolytic Regimen 3 Plus

      -Trial Overview (AHA 2002)

ASSENT-4 PCI: Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction - 4 PCI Trial

      -Trial Overview by Dr. Frans Van de Werf (European Society of Cariology 2005)

 

ASSERT: First Major Clinical Trial of an Oral Agent Inducing Apo-A-I Synthesis: A New Approach to Raising HDL and CV Risk Modification

      -Trial Results by Dr. Stephen Nicholls (AHA 2010)

The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel

      -The Association of Cigarette Smoking With Enhanced Platelet Inhibition by Clopidogrel by Kevin P. Bliden

ASTEROID: A Study To Evaluate the Effect of Rosuvastatin on Intravascular Ultrasound-Derived Coronary Atheroma Burden

      -Trial Overview (2008) by Dr. Christie M. Ballantyne (ACC 2008)

      -Trial Overview (2006) by Dr. Steven E. Nissen (ACC 2006)

ASTRAL: Angioplasty and Stent for Renal Artery Lesions

      -Trial Overview by Dr. Philip A. Kalra

ATHENA: A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death from any Cause in Patients with Atrial Fibrillation/Atrial Flutter

      -Trial Overview by Dr. Stefan H. Hohnloser (Heart Rhythm 2008)

ATTEMPT: Pooled-Analysis of Trials on Thrombectomy in Acute Myocardial Infarction Based on Individual Patient Data

      -Trial Overview by Dr. Francesco Burzotta (ESC 2009)

AVERT: Atorvastatin Versus Revascularization Treatments Trial

      -Trial Overview by Dr. Bertram Pitt (AHA 1998)

 

AVIO: A Prospective, Randomized Trial of Intravascular-Ultrasound Guided Compared to Angiography Guided Stent Implantation in Complex Coronary Lesions

      -Trial Overview by Dr. Antonio Colombo (TCT 2010)

Who Are We?    Slide Downloading Policy   Financial Disclosure    We Do Not Promote Off Label Product Use    Copyright    Source of Slides    Editorial Policy    Links Policy    Privacy Policy   Access    CME Programs

© 1999-2009 by Clinical Trial Results .org.  None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results.  All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster

Last Edited and Updated 01/15/2013 08:58:04 AM -0500